Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

Illumina launched the Billion Cell Atlas to train AI on one billion single cells. AstraZeneca, Merck and Lilly are founding ...

AI across the pharmaceutical ecosystem. The Illumina Billion Cell Atlas is the first tranche of its program to build a 5 billion cell atlas over three years, and will be the most comprehensive map of ...

Cancer immunity and immunotherapy research increasingly recognizes that chronic inflammation is a major driver of tumorigenesis, yet the complex and dynamic ...

AI Impact explores why AI security has outgrown human oversight, plus pricing gains, health care insight and key AI moves in ...